Skip to main content
Erschienen in: Journal of Nuclear Cardiology 3/2021

13.05.2020 | ORIGINAL ARTICLE

Left ventricular systolic and diastolic dyssynchrony to improve cardiac resynchronization therapy response in heart failure patients with dilated cardiomyopathy

verfasst von: Cheng Wang, MD, Jianzhou Shi, MS, Jiacheng Ge, MS, Haipeng Tang, MS, Zhuo He, BS, Yanyun Liu, BS, Zhongqiang Zhao, BS, Chunxiang Li, BS, Kai Gu, MD, Xiaofeng Hou, MD, Minglong Chen, MD, Jiangang Zou, MD, Lei Zhou, MD, Ernest V. Garcia, PhD, Dianfu Li, MD, Weihua Zhou, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The systolic and diastolic dyssynchrony is physiologically related, but measure different left ventricular mechanisms. Left ventricular systolic mechanical dyssynchrony (systolic LVMD) has shown significant clinical values in improving cardiac resynchronization therapy (CRT) response in the heart failure patients with dilated cardiomyopathy (DCM). Our recent study demonstrated that LV diastolic dyssynchrony (diastolic LVMD) parameters have important prognostic values for DCM patients. However, there are a limited number of studies about the clinical value of diastolic LVMD for CRT. This study aims to explore the predictive values of both systolic LVMD and diastolic LVMD for CRT in DCM patients.

Methods

Eighty-four consecutive CRT patients with both DCM and complete left bundle branch block (CLBBB) who received gated resting SPECT MPI at baseline were included in the present study. The phase analysis technique was applied on resting gated short-axis SPECT MPI images to measure systolic LVMD and diastolic LVMD, characterized by phase standard deviation (PSD) and phase histogram bandwidth (PBW). CRT response was defined as ≥ 5% improvement of LVEF at 6-month follow-up. Variables with P < 0.10 in the univariate analysis were included in the multivariate cox analysis.

Results

During the follow-up period, 59.5% (50 of 84) patients were CRT responders. The univariate cox regression analysis showed that at baseline QRS duration, non-sustained ventricular tachycardia (NS-VT), systolic PSD, systolic PBW, diastolic PSD, diastolic PBW, scar burden and LV lead in the scarred myocardium were statistically significantly associated with CRT response. The multivariate cox regression analysis showed that QRS duration, NS-VT, systolic PSD, systolic PBW, diastolic PSD, and diastolic PBW were independent predictive factors for CRT response. Furthermore, the rate of CRT response was 94.4% (17 of 18) in patients whose LV lead was in the segments with both the first three late contraction and the first three late relaxation; by contrast, the rate of CRT response was only 6.7% (1 of 15, P < 0.000) in patients whose LV lead was in the segments with neither the first three late contraction nor the first three late relaxation.

Conclusion

Both systolic LVMD and diastolic LVMD from gated SPECT MPI have important predictive values for CRT response in DCM patients. Pacing at LV segments with both late contraction and late relaxation has potential to increase the CRT response.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.CrossRef Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.CrossRef
2.
Zurück zum Zitat Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.CrossRef Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.CrossRef
3.
Zurück zum Zitat McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: A systematic review. JAMA 2007;297:2502-14.CrossRef McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: A systematic review. JAMA 2007;297:2502-14.CrossRef
4.
Zurück zum Zitat Zhou W, Garcia EV. Nuclear image-guided approaches for cardiac resynchronization therapy (CRT). Curr Cardiol Rep 2016;18:7.CrossRef Zhou W, Garcia EV. Nuclear image-guided approaches for cardiac resynchronization therapy (CRT). Curr Cardiol Rep 2016;18:7.CrossRef
5.
Zurück zum Zitat Boogers MJ, Chen J, van Bommel RJ, Borleffs CJ, Dibbets-Schneider P, van der Hiel B, et al. Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2011;38:230-8.CrossRef Boogers MJ, Chen J, van Bommel RJ, Borleffs CJ, Dibbets-Schneider P, van der Hiel B, et al. Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2011;38:230-8.CrossRef
6.
Zurück zum Zitat Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1402-9.CrossRef Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1402-9.CrossRef
7.
Zurück zum Zitat Friehling M, Chen J, Saba S, Bazaz R, Schwartzman D, Adelstein EC, et al. A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol. Circ Cardiovasc Imaging 2011;4:532-9.CrossRef Friehling M, Chen J, Saba S, Bazaz R, Schwartzman D, Adelstein EC, et al. A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol. Circ Cardiovasc Imaging 2011;4:532-9.CrossRef
8.
Zurück zum Zitat Verbrugge FH, Verhaert D, Grieten L, Dupont M, Rivero-Ayerza M, De Vusser P, et al. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy. Europace 2013;15:1747-56.CrossRef Verbrugge FH, Verhaert D, Grieten L, Dupont M, Rivero-Ayerza M, De Vusser P, et al. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy. Europace 2013;15:1747-56.CrossRef
9.
Zurück zum Zitat Boogers MJ, Chen J, Veltman CE, van Bommel RJ, Mooyaart EA, Al Younis I, et al. Left ventricular diastolic dyssynchrony assessed with phase analysis of gated myocardial perfusion SPECT: A comparison with tissue Doppler imaging. Eur J Nucl Med Mol Imaging 2011;38:2031-9.CrossRef Boogers MJ, Chen J, Veltman CE, van Bommel RJ, Mooyaart EA, Al Younis I, et al. Left ventricular diastolic dyssynchrony assessed with phase analysis of gated myocardial perfusion SPECT: A comparison with tissue Doppler imaging. Eur J Nucl Med Mol Imaging 2011;38:2031-9.CrossRef
10.
Zurück zum Zitat Hsu TH, Huang WS, Chen CC, Hung GU, Chen TC, Kao CH, et al. Left ventricular systolic and diastolic dyssynchrony assessed by phase analysis of gated SPECT myocardial perfusion imaging: A comparison with speckle tracking echocardiography. Ann Nucl Med 2013;27:764-71.CrossRef Hsu TH, Huang WS, Chen CC, Hung GU, Chen TC, Kao CH, et al. Left ventricular systolic and diastolic dyssynchrony assessed by phase analysis of gated SPECT myocardial perfusion imaging: A comparison with speckle tracking echocardiography. Ann Nucl Med 2013;27:764-71.CrossRef
11.
Zurück zum Zitat Fudim M, Dalgaard F, Fathallah M, Iskandrian AE, Borges-Neto S. Mechanical dyssynchrony: How do we measure it, what it means, and what we can do about it. J Nucl Cardiol 2019;29:43-52. Fudim M, Dalgaard F, Fathallah M, Iskandrian AE, Borges-Neto S. Mechanical dyssynchrony: How do we measure it, what it means, and what we can do about it. J Nucl Cardiol 2019;29:43-52.
13.
Zurück zum Zitat Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6.CrossRef Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6.CrossRef
14.
Zurück zum Zitat Chen J, Kalogeropoulos AP, Verdes L, Butler J, Garcia EV. Left-ventricular systolic and diastolic dyssynchrony as assessed by multi-harmonic phase analysis of gated SPECT myocardial perfusion imaging in patients with end-stage renal disease and normal LVEF. J Nucl Cardiol 2011;18:299-308.CrossRef Chen J, Kalogeropoulos AP, Verdes L, Butler J, Garcia EV. Left-ventricular systolic and diastolic dyssynchrony as assessed by multi-harmonic phase analysis of gated SPECT myocardial perfusion imaging in patients with end-stage renal disease and normal LVEF. J Nucl Cardiol 2011;18:299-308.CrossRef
15.
Zurück zum Zitat White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48:1953-60.CrossRef White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48:1953-60.CrossRef
16.
Zurück zum Zitat Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007;153:105-12.CrossRef Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007;153:105-12.CrossRef
17.
Zurück zum Zitat Sciagra R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P, et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 2004;45:164-8.PubMed Sciagra R, Giaccardi M, Porciani MC, Colella A, Michelucci A, Pieragnoli P, et al. Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 2004;45:164-8.PubMed
18.
Zurück zum Zitat Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011;32:93-103.CrossRef Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011;32:93-103.CrossRef
19.
Zurück zum Zitat Riedlbauchova L, Brunken R, Jaber WA, Popova L, Patel D, Lanska V, et al. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009;20:50-7.CrossRef Riedlbauchova L, Brunken R, Jaber WA, Popova L, Patel D, Lanska V, et al. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009;20:50-7.CrossRef
20.
Zurück zum Zitat Lalonde M, Birnie D, Ruddy TD, deKemp RA, Beanlands RS, Wassenaar R, et al. SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response. Int J Cardiovasc Imaging 2014;30:559-69.CrossRef Lalonde M, Birnie D, Ruddy TD, deKemp RA, Beanlands RS, Wassenaar R, et al. SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response. Int J Cardiovasc Imaging 2014;30:559-69.CrossRef
21.
Zurück zum Zitat Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41.CrossRef Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41.CrossRef
22.
Zurück zum Zitat Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.CrossRef Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.CrossRef
23.
Zurück zum Zitat Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC, et al. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 2006;97:1615-21.CrossRef Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC, et al. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 2006;97:1615-21.CrossRef
24.
Zurück zum Zitat Sieniewicz BJ, Gould J, Porter B, Sidhu BS, Teall T, Webb J, et al. Understanding non-response to cardiac resynchronisation therapy: Common problems and potential solutions. Heart Fail Rev 2019;24:41-54.CrossRef Sieniewicz BJ, Gould J, Porter B, Sidhu BS, Teall T, Webb J, et al. Understanding non-response to cardiac resynchronisation therapy: Common problems and potential solutions. Heart Fail Rev 2019;24:41-54.CrossRef
25.
Zurück zum Zitat Haugaa KH, Dan GA, Iliodromitis K, Lenarczyk R, Marinskis G, Osca J, et al. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death-translating guidelines into practice: Results of the European Heart Rhythm Association survey. Europace 2018;20:f249-53.CrossRef Haugaa KH, Dan GA, Iliodromitis K, Lenarczyk R, Marinskis G, Osca J, et al. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death-translating guidelines into practice: Results of the European Heart Rhythm Association survey. Europace 2018;20:f249-53.CrossRef
26.
Zurück zum Zitat Zhou Y, Faber TL, Patel Z, Folks RD, Cheung AA, Garcia EV, et al. An automatic alignment tool to improve repeatability of left ventricular function and dyssynchrony parameters in serial gated myocardial perfusion SPECT studies. Nucl Med Commun 2013;34:124-9.CrossRef Zhou Y, Faber TL, Patel Z, Folks RD, Cheung AA, Garcia EV, et al. An automatic alignment tool to improve repeatability of left ventricular function and dyssynchrony parameters in serial gated myocardial perfusion SPECT studies. Nucl Med Commun 2013;34:124-9.CrossRef
27.
Zurück zum Zitat Beela AS, Unlu S, Duchenne J, Ciarka A, Daraban AM, Kotrc M, et al. Assessment of mechanical dyssynchrony can improve the prognostic value of guideline-based patient selection for cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2019;20:66-74.CrossRef Beela AS, Unlu S, Duchenne J, Ciarka A, Daraban AM, Kotrc M, et al. Assessment of mechanical dyssynchrony can improve the prognostic value of guideline-based patient selection for cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2019;20:66-74.CrossRef
28.
Zurück zum Zitat Tayal B, Gorcsan J 3rd, Bax JJ, Risum N, Olsen NT, Singh JP, et al. Cardiac resynchronization therapy in patients with heart failure and narrow QRS complexes. J Am Coll Cardiol 2018;71:1325-33.CrossRef Tayal B, Gorcsan J 3rd, Bax JJ, Risum N, Olsen NT, Singh JP, et al. Cardiac resynchronization therapy in patients with heart failure and narrow QRS complexes. J Am Coll Cardiol 2018;71:1325-33.CrossRef
31.
Zurück zum Zitat Schuster I, Habib G, Jego C, Thuny F, Avierinos JF, Derumeaux G, et al. Diastolic asynchrony is more frequent than systolic asynchrony in dilated cardiomyopathy and is less improved by cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2250-7.CrossRef Schuster I, Habib G, Jego C, Thuny F, Avierinos JF, Derumeaux G, et al. Diastolic asynchrony is more frequent than systolic asynchrony in dilated cardiomyopathy and is less improved by cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2250-7.CrossRef
32.
Zurück zum Zitat Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol 2007;49:88-96.CrossRef Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol 2007;49:88-96.CrossRef
33.
Zurück zum Zitat Fudim M, Fathallah M, Shaw LK, Liu PR, James O, Samad Z, et al. The prognostic value of diastolic and systolic mechanical left ventricular dyssynchrony among patients with coronary heart disease. JACC Cardiovasc Imaging 2019;12:1215-26.CrossRef Fudim M, Fathallah M, Shaw LK, Liu PR, James O, Samad Z, et al. The prognostic value of diastolic and systolic mechanical left ventricular dyssynchrony among patients with coronary heart disease. JACC Cardiovasc Imaging 2019;12:1215-26.CrossRef
35.
Zurück zum Zitat Morris-Thurgood JA, Turner MS, Nightingale AK, Masani N, Mumford C, Frenneaux MP. Pacing in heart failure: Improved ventricular interaction in diastole rather than systolic re-synchronization. Europace 2000;2:271-5. discussion 6.CrossRef Morris-Thurgood JA, Turner MS, Nightingale AK, Masani N, Mumford C, Frenneaux MP. Pacing in heart failure: Improved ventricular interaction in diastole rather than systolic re-synchronization. Europace 2000;2:271-5. discussion 6.CrossRef
36.
Zurück zum Zitat Bleasdale RA, Turner MS, Mumford CE, Steendijk P, Paul V, Tyberg JV, et al. Left ventricular pacing minimizes diastolic ventricular interaction, allowing improved preload-dependent systolic performance. Circulation 2004;110:2395-400.CrossRef Bleasdale RA, Turner MS, Mumford CE, Steendijk P, Paul V, Tyberg JV, et al. Left ventricular pacing minimizes diastolic ventricular interaction, allowing improved preload-dependent systolic performance. Circulation 2004;110:2395-400.CrossRef
37.
Zurück zum Zitat Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O’Halloran D, Elsik M, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: The TARGET study: A randomized, controlled trial. J Am Coll Cardiol 2012;59:1509-18.CrossRef Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O’Halloran D, Elsik M, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: The TARGET study: A randomized, controlled trial. J Am Coll Cardiol 2012;59:1509-18.CrossRef
38.
Zurück zum Zitat Kockova R, Sedlacek K, Wichterle D, Sikula V, Tintera J, Jansova H, et al. Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT). Int J Cardiol 2018;270:325-30.CrossRef Kockova R, Sedlacek K, Wichterle D, Sikula V, Tintera J, Jansova H, et al. Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT). Int J Cardiol 2018;270:325-30.CrossRef
39.
Zurück zum Zitat Sommer A, Kronborg MB, Norgaard BL, Poulsen SH, Bouchelouche K, Bottcher M, et al. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: A randomized controlled trial. Eur J Heart Fail 2016;18:1365-74.CrossRef Sommer A, Kronborg MB, Norgaard BL, Poulsen SH, Bouchelouche K, Bottcher M, et al. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: A randomized controlled trial. Eur J Heart Fail 2016;18:1365-74.CrossRef
Metadaten
Titel
Left ventricular systolic and diastolic dyssynchrony to improve cardiac resynchronization therapy response in heart failure patients with dilated cardiomyopathy
verfasst von
Cheng Wang, MD
Jianzhou Shi, MS
Jiacheng Ge, MS
Haipeng Tang, MS
Zhuo He, BS
Yanyun Liu, BS
Zhongqiang Zhao, BS
Chunxiang Li, BS
Kai Gu, MD
Xiaofeng Hou, MD
Minglong Chen, MD
Jiangang Zou, MD
Lei Zhou, MD
Ernest V. Garcia, PhD
Dianfu Li, MD
Weihua Zhou, PhD
Publikationsdatum
13.05.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2021
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02132-1

Weitere Artikel der Ausgabe 3/2021

Journal of Nuclear Cardiology 3/2021 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.